• Proceedings of the Korean Institute of Communication Sciences Conference
• /
• 2006.07a
• /
• pp.514-514
• /
• 2006

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.1
• /
• pp.3-10
• /
• 2014

The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

• Asian Pacific Journal of Cancer Prevention
• /
• v.16 no.1
• /
• pp.1-8
• /
• 2015

The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized a Roundtable Discussion as part of the official program of the UICC World Cancer Congress 2014 in Melbourne, Australia. The theme for the Roundtable Discussion was "Looking Toward the Realization of Universal Health Care 'UHC' for Cancer in Asia" and it was held on December 5, 2014. The meeting was held based on the recognition that although each country may take a different path towards the realization of UHC, one point that is common to all is that cancer is projected to be the most difficult disease to address under the goals of UHC and that there is, therefore, an urgent and pressing need to come to a common understanding and awareness with regard to UHC concepts that are a priority component of a post-MDG development agenda. The presenters and participants addressed the issue of UHC for cancer in Asia from their various perspectives in academia and international organizations. Discussions covered the challenges to UHC in Asia, collaborative approaches by international organizations, the need for uniform and relevant data, ways to create an Asia Cancer Barometer that could be applied to all countries in Asia. The session concluded with the recognition that research on UHC in Asia should continue to be used as a tool for cancer cooperation in Asia and that the achievement of UHC would require research and input not only from the medical community, but from a broad sector of society in a multidisciplinary approach. Discussions on this issue will continue towards the Asia-Pacific Cancer Conference in Indonesia in August 2015.

• Asian Pacific Journal of Cancer Prevention
• /
• v.14 no.8
• /
• pp.4935-4937
• /
• 2013

At the United Nations High-level Meeting on Non-communicable Disease Prevention and Control in 2011 the link between health and socioeconomic issues was raised, becoming a global political issue. Health equity is one challenge that has hitherto not been addressed directly, although there is a growing shared recognition that cancer in Asia is an urgent social issue. At the UICC-ARO we are working to promote and widen networks of individuals and organizations in Asia and involve them in cooperation for this purpose. As part of our current activities, we are addressing the question of the "Economic burden of cancer in Asian countries: How should we face the current situation?" from a variety of angles and seeking to bring together a wealth of multidisciplinary knowledge about cancer in Asia and its related socioeconomic factors. It is essential to ensure that the real picture of cancer in Asia, which is currently not accurately understood, is conveyed clearly to all concerned, and also that the differences between cancer in Asia and in the West are highlighted.

• 한국정보통신설비학회:학술대회논문집
• /
• 2008.08a
• /
• pp.355-359
• /
• 2008

와이브로(WiBro), 3G 무선인터넷(HSDPA), 3G LTE 등과 같은 와이어리스 브로드밴드(Wireless Broand) 기술이 점차 성숙됨에 따라 이들 망을 활용한 다양한 무선인터넷 서비스를 제공하려는 사업자들이 증가하고 있다. 기존의 WLAN, 2G/3G 회선망에서의 제한된 이동성 및 네트워크 전송 속도를 개선한 와이어리스 브로드밴드 서비스 시장은 국내에서도 2006년부터 WiBro 및 HSDPA가 사용됨에 따라 사업자간의 경쟁도 본격화되고 있다. 이러한 환경 속에서 사업자들은 신속하고 편리한 서비스 개통과 스마트폰, USB모뎀, 노트북, UMPC, PMP등 다양한 단말들의 펌웨어 업그레이드, A/S 처리 방안에 대해 고심을 하고 있으며, 이들 문제점은 막대한 비용과 고객 민원을 야기시키는 요인이기도 하다. 따라서 경제적인 관리비용으로 동적인 서비스/펌웨어 업그레이드 및 A/S에 대한 고객 만족도를 높이기 위한 단말 원격 관리 필요성이 절실히 요구된다. WiBro 단말의 안전하고 효율적으로 관리하기 위해서는 단말과 기지국사이의 무선구간에 대한 보안(security)을 강화시켜 줄 수 있으면서 이동성(mobility)을 고려한 OMA DM프로토콜을 이용하는 것이 적합하다. 또한, WiBro에서 가입자 인증을 채택하고 있는 UICC의 관리를 위해서 3GPP에서 정의하는 SMS/MMS기반의 또는 BIP(Bear Independent Protocol)기반의 OTA기술을 병행하여 사용하여야 한다. 본 논문에서는 Wi-MAX단말 관리를 위한 OTA Provisioning 규격으로 OMA DM과 TR069이 WiMAX 단말을 위하여 어떻게 적용하도록 규정하고 있는지를 살펴본다. 특히, WiBro 가입자 인증뿐만 아니라 폰북, DRM, 금융서비스 등 다양한 부가 서비스를 위하여 사용되는 UICC의 원격관리를 위한 관리 요소들을 정의, 설계하고 이를 바탕으로 구현된 KTUICC OTA Provisioning시스템을 소개한다.

• TTA Journal
• /
• s.152
• /
• pp.56-59
• /
• 2014

• Proceedings of the Korea Information Processing Society Conference
• /
• 2008.05a
• /
• pp.1159-1162
• /
• 2008

언제 어디서나 인터넷에 접속하여 필요한 정보를 얻을 수 있는 서비스를 Wibro(Wireless Broadband)라고 한다. 서비스를 제공하기 위해 중요한 기술요소 중 하나가 보안이다. 최근 보다 안전한인증 메커니즘을 설계할 수 있는 UICC기반의 EAP-AKA프로토콜이 제안되었다. 그러나 이 프로토콜은 프라이버시 보호 문제와, 인증서버에 저장공간 오버헤드, 비밀키 노출에 따른 전방향 안전성제공의 문제점들이 있다. 본 논문에서는 UICC기반의 EAP-AKA프로토콜의 문제점을 살펴보고 이러한 문제점을 해결하기 위한 전방향 안정성을 제공하는 Wibro인증 및 키 동의 프로토콜을 제안한다.

• International Journal of Computer Science & Network Security
• /
• v.24 no.5
• /
• pp.73-78
• /
• 2024

COVID-19 pandemic outbreak increased the use of Internet of Medical Things (IoMT), but the existing IoMT solutions are not free from attacks. This paper proposes a secure and resilient framework for IoMT, it computes the risk using Risk Impact Parameters (RIP) and Risk is also calculated based upon the Threat Events in the Internet of Medical Things (IoMT). UICC (Universal Integrated Circuit Card) and TPM (Trusted Platform Module) are used to ensure security in IoMT. PILAR Risk Management Tool is used to perform qualitative and quantitative risk analysis. It is designed to support the risk management process along long periods, providing incremental analysis as the safeguards improve.

• Korean Journal of Head & Neck Oncology
• /
• v.8 no.1
• /
• pp.37-43
• /
• 1992

In order to improve the control of large unresectable(>6cm) and fixed N3(TNM-UICC) metastatic neck nodes, local hyperthermia(HT) has been combined with radiation therapty (RT) in Yonsei cancer center. From April 1985 to april 1988, a total of 18 patients of head and neck cancer with metastatic large unresectable and fixed cervical neck nodes who underwent combined RT and HT were analyzed. Of 18 patients, complete response rate was 39% (7 pt.) partial response 39% (7 pt.) and overall response rate was 78%. Acute side effects of these combined modalities were found in 8 patients and which were mainly cutaneous reaction such as erythema, dry and moist desquamation but recovered spontaneously in all patients after treatment. Factors of maximum tumor temperature above $43^{\circ}\C$ and MDF(multiple daily fractionation) showed more favorable response rate but not statistically sinificant. Two year actuarial survival rate of all patients was 35.4%.

• Radiation Oncology Journal
• /
• v.36 no.4
• /
• pp.295-303
• /
• 2018

Purpose: We evaluated prognostic value of the 8th edition of the American Joint Committee on Cancer/International Union for Cancer Control (AJCC/UICC) staging system for nasopharyngeal cancer and investigated whether tumor volume/metabolic information refined prognostication of anatomy based staging system. Materials and Methods: One hundred thirty-three patients with nasopharyngeal cancer who were staged with magnetic resonance imaging (MRI) and treated with intensity-modulated radiotherapy (IMRT) between 2004 and 2013 were reviewed. Multivariate analyses were performed to evaluate prognostic value of the 8th edition of the AJCC/UICC staging system and other factors including gross tumor volume and maximum standardized uptake value of primary tumor (GTV-T and SUV-T). Results: Median follow-up period was 63 months. In multivariate analysis for overall survival (OS), stage group (stage I-II vs. III-IVA) was the only significant prognostic factor. However, 5-year OS rates were not significantly different between stage I and II (100% vs. 96.2%), and between stage III and IVA (80.1% vs. 71.7%). Although SUV-T and GTV-T were not significant prognostic factors in multivariate analysis, those improved prognostication of stage group. The 5-year OS rates were significantly different between stage I-II, III-IV (SUV-T ≤ 16), and III-IV (SUV-T > 16) (97.2% vs. 78% vs. 53.8%), and between stage I, II-IV (GTV-T ≤ 33 mL), and II-IV (GTV-T > 33 mL) (100% vs. 87.3% vs. 66.7%). Conclusion: Current anatomy based staging system has limitations on prognostication for nasopharyngeal cancer despite the most accurate assessment of tumor extent by MRI. Tumor volume/metabolic information seem to improve prognostication of current anatomy based staging system, and further studies are needed to confirm its clinical significance.